BDBM771836 14-chloro-20,22-difluoro-15-hydroxy-10-methyl-17,17-dioxo-17λ6-thia-10,18-diazatetracyclo[17.3.1.112,16.02,7]tetracosa-1(22),2(7),3,5,12,14,16(24),19(23),20-nonaen-11-one ::US20250289793, Compound 71

SMILES CN1CCc2ccccc2-c2cc(c(F)cc2F)NS(=O)(=O)c2cc(cc(Cl)c2O)C1=O

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 771836   

TargetATP-citrate synthase(Human)
Esperion Therapeutics

US Patent
LigandPNGBDBM771836(14-chloro-20,22-difluoro-15-hydroxy-10-methyl-17,1...)
Affinity DataIC50: 20nMAssay Description:Table 2: Compounds of the disclosure were evaluated for their efficacy in inhibiting hACLY using rapid fire mass spectrometry (RF/MS). The final reac...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent